Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer.
Authors: Lee, Ye Jin1 (AUTHOR), Park, Young Sik1 (AUTHOR), Lee, Hyun Woo2 (AUTHOR), Park, Tae Yoen2 (AUTHOR), Lee, Jung Kyu2 (AUTHOR), Heo, Eun Young2 (AUTHOR) eunyoungheo@gmail.com
Source: Scientific Reports. 1/12/2022, Vol. 12 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-021-04630-9